Abstract
First‐degree relatives of patients diagnosed with schizophrenia (SZ‐FDRs) show similar patterns of brain abnormalities and cognitive alterations to patients, albeit with smaller effect sizes. First‐degree relatives of patients diagnosed with bipolar disorder (BD‐FDRs) show divergent patterns; on average, intracranial volume is larger compared to controls, and findings on cognitive alterations in BD‐FDRs are inconsistent. Here, we performed a meta‐analysis of global and regional brain measures (cortical and subcortical), current IQ, and educational attainment in 5,795 individuals (1,103 SZ‐FDRs, 867 BD‐FDRs, 2,190 controls, 942 schizophrenia patients, 693 bipolar patients) from 36 schizophrenia and/or bipolar disorder family cohorts, with standardized methods. Compared to controls, SZ‐FDRs showed a pattern of widespread thinner cortex, while BD‐FDRs had widespread larger cortical surface area. IQ was lower in SZ‐FDRs (d = −0.42,p = 3 × 10−5), with weak evidence of IQ reductions among BD‐FDRs (d = −0.23,p = .045). Both relative groups had similar educational attainment compared to controls. When adjusting for IQ or educational attainment, the group‐effects on brain measures changed, albeit modestly. Changes were in the expected direction, with less pronounced brain abnormalities in SZ‐FDRs and more pronounced effects in BD‐FDRs. To conclude, SZ‐FDRs and BD‐FDRs show a differential pattern of structural brain abnormalities. In contrast, both had lower IQ scores and similar school achievements compared to controls. Given that brain differences between SZ‐FDRs and BD‐FDRs remain after adjusting for IQ or educational attainment, we suggest that differential brain developmental processes underlying predisposition for schizophrenia or bipolar disorder are likely independent of general cognitive impairment.
Funding Information
  • Canadian Institutes of Health Research (103703, 106469, 142255)
  • Deutsche Forschungsgemeinschaft (1617)
  • Generalitat de Catalunya (2017SGR01271)
  • Medical Research Council Canada (G0901310)
  • Ministerstvo Zdravotnictví Ceské Republiky (NR8786, NT13891)
  • National Alliance for Research on Schizophrenia and Depression (17319, 20244, 26731)
  • National Centre of Competence in Research Robotics (51NF40‐185897)
  • National Institute of Mental Health (1S10OD017974‐01, P30 NS076408, R01 MH052857, R01 MH080912, R01 MH113619, U01 MH108150, R01 MH085667)
  • National Institute on Aging (T32AG058507)
  • National Institutes of Health (P41 EB015922, R01 MH111671, R01 MH116147, R01 MH117601, R01MH121246, R03 MH105808, U54EB020403)
  • Norges Forskningsråd (223273)
  • Instituto de Salud Carlos III (CPII19/00009, PI070066, PI1100683, PI1500467, PI18/00976)
  • Stanley Medical Research Institute
  • Vetenskapsrådet (K2007‐62X‐15077‐04‐1, K2008‐62P‐20597‐01‐3, K2010‐62X‐15078‐07‐2, K2012‐61X‐15078‐09‐3)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (32003B_156914)
  • Wellcome Trust (085475/B/08/Z, 085475/Z/08/Z)
  • ZonMw (908‐02‐123)

This publication has 60 references indexed in Scilit: